Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urinary potassium refers to the quantity of potassium ions excreted in the urine, which reflects renal potassium handling through the combined processes of filtration, reabsorption, and secretion primarily in the distal nephron, including the distal convoluted tubule and collecting duct. This parameter is commonly measured to assess potassium homeostasis, distinguish renal from extrarenal potassium wasting, and monitor patients on diuretics or with suspected electrolyte disorders. Potassium excretion is regulated by hormones (e.g., aldosterone), dietary intake, blood pH, and the activity of renal transport systems such as Na-K-ATPase, luminal potassium channels (ROMK, Maxi-K), and potassium-chloride cotransporters.
drugs influence urinary potassium excretion mainly by affecting Na-K-ATPase, renal potassium channels (ROMK, Maxi-K), or aldosterone-sensitive pathways
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on urinary potassium.